Literature DB >> 31788134

Kemp Eliminases of the AlleyCat Family Possess High Substrate Promiscuity.

Elizabeth A Caselle1, Jennifer H Yoon1, Sagar Bhattacharya1, Joel J L Rempillo1, Zsófia Lengyel1, Areetha D'Souza1, Yurii S Moroz2, Patricia L Tolbert1, Alexander N Volkov3,4, Marcello Forconi5, Carlos A Castañeda1, Olga V Makhlynets1, Ivan V Korendovych1.   

Abstract

Minimalist enzymes designed to catalyze model reactions provide useful starting points for creating catalysts for practically important chemical transformations. We have shown that Kemp eliminases of the AlleyCat family facilitate conversion of leflunomide (an immunosupressor pro-drug) to its active form teriflunomide with outstanding rate enhancement (nearly four orders of magnitude) and catalytic proficiency (more than seven orders of magnitude) without any additional optimization. This remarkable activity is achieved by properly positioning the substrate in close proximity to the catalytic glutamate with very high pKa.

Entities:  

Keywords:  Kemp elimination; Nuclear Magnetic Resonance; allostery; calmodulin; protein design

Year:  2019        PMID: 31788134      PMCID: PMC6884320          DOI: 10.1002/cctc.201801994

Source DB:  PubMed          Journal:  ChemCatChem        ISSN: 1867-3880            Impact factor:   5.686


  33 in total

1.  Many pathways in laboratory evolution can lead to improved enzymes: how to escape from local minima.

Authors:  Yosephine Gumulya; Joaquin Sanchis; Manfred T Reetz
Journal:  Chembiochem       Date:  2012-04-20       Impact factor: 3.164

2.  Alternate-site enzyme promiscuity.

Authors:  Andreas Taglieber; Horst Höbenreich; J Daniel Carballeira; Régis J G Mondière; Manfred T Reetz
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

3.  Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series.

Authors:  Olga Khersonsky; Daniela Röthlisberger; Orly Dym; Shira Albeck; Colin J Jackson; David Baker; Dan S Tawfik
Journal:  J Mol Biol       Date:  2009-12-28       Impact factor: 5.469

4.  A Promiscuous De Novo Retro-Aldolase Catalyzes Asymmetric Michael Additions via Schiff Base Intermediates.

Authors:  Xavier Garrabou; Tobias Beck; Donald Hilvert
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-16       Impact factor: 15.336

Review 5.  Protein design, a minimalist approach.

Authors:  W F DeGrado; Z R Wasserman; J D Lear
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

6.  Enzyme design: Functional Frankensteins.

Authors:  Olga V Makhlynets; Ivan V Korendovych
Journal:  Nat Chem       Date:  2016-08-24       Impact factor: 24.427

7.  The role of protein dynamics in the evolution of new enzyme function.

Authors:  Eleanor Campbell; Miriam Kaltenbach; Galen J Correy; Paul D Carr; Benjamin T Porebski; Emma K Livingstone; Livnat Afriat-Jurnou; Ashley M Buckle; Martin Weik; Florian Hollfelder; Nobuhiko Tokuriki; Colin J Jackson
Journal:  Nat Chem Biol       Date:  2016-09-12       Impact factor: 15.040

8.  Enantiocomplementary Synthesis of γ-Nitroketones Using Designed and Evolved Carboligases.

Authors:  Xavier Garrabou; Rebecca Verez; Donald Hilvert
Journal:  J Am Chem Soc       Date:  2016-12-22       Impact factor: 15.419

9.  Functional tuning of the catalytic residue pKa in a de novo designed esterase.

Authors:  Katharina Hiebler; Zsófia Lengyel; Carlos A Castañeda; Olga V Makhlynets
Journal:  Proteins       Date:  2017-06-07

10.  A single mutation in a regulatory protein produces evolvable allosterically regulated catalyst of nonnatural reaction.

Authors:  Olesia V Moroz; Yurii S Moroz; Yibing Wu; Alissa B Olsen; Hong Cheng; Korrie L Mack; Jaclyn M McLaughlin; Elizabeth A Raymond; Krystyna Zhezherya; Heinrich Roder; Ivan V Korendovych
Journal:  Angew Chem Int Ed Engl       Date:  2013-04-29       Impact factor: 15.336

View more
  1 in total

1.  Minimalist de novo Design of Protein Catalysts.

Authors:  Liam R Marshall; Oleksii Zozulia; Zsofia Lengyel-Zhand; Ivan V Korendovych
Journal:  ACS Catal       Date:  2019-09-13       Impact factor: 13.084

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.